Is Clovis Oncology a Wolf in Sheep's Clothing?
Shares of clinical-stage cancer treatment developer Clovis soared yesterday after a report that it's shopping itself around. Does Clovis really have anything to offer a prospective buyer?
Is Another Biotech Buyout on the Horizon?
What makes ViroPharma an attractive target for big pharma Sanofi and orphan drug specialist Shire?
Theravance Gets Big Win for New COPD Drug
An FDA panel gives a big thumbs-up for Theravance's Anoro Ellipta.
Shorts Are Piling Into These Stocks. Should You Be Worried?
Do short-sellers have these stocks pegged? You be the judge!
Here's What This 758% Gainer Has Been Buying
It can pay off to keep an eye on activist investors and the changes they're agitating for.